Metastasis is the primary cause of death for most cancer patients. Hematogenous arrest of circulating tumor cells (CTCs) is an essential prerequisite for metastases formation. Using transparent transgenic zebrafish (kdrl:eGFP; Casper), together with resonant laser scanning confocal microscopy, we tracked the fate of CTCs in vivo in the blood circulation for days. We found the intra-capillary morphology-switch (ICMS) of individual CTCs from strip to sphere was necessary for their intravascular arrests. Further genetic and pharmacological inhibition experiments indicated that the RhoA signaling was necessary for ICMS and the arrest of CTCs. At last, we demonstrated that early treatment by a clinically approved RhoA/ROCK inhibitor, Fasudil, could efficiently inhibit the initial arrest of individual CTCs and reduce the incidence of tumor metastasis in both zebrafish and mouse models. These results together indicate that RhoA-stimulated ICMS represents a mechanism for the arrest of individual CTCs, providing a potential target for future treatments of hematogenous metastatic disease.
Metastasis is the leading cause of cancer mortality. The ability of malignant tumor to form secondary micrometastases depends on successful progression through multiple steps, from shedding of tumor cells by the primary tumor into the bloodstream (or lymphatics) through extravasation of circulating tumor cells (CTCs) and eventual growth at distant foci. 1 A full understanding of the essential and inefficient steps of the metastatic cascade is needed, which could have major implications for the design of improved therapies. Several in vivo models have been applied to study the metastatic cascade. [2] [3] [4] [5] [6] Using in vivo Multiphoton Laser-scanning Microscopy (MPLSM), Kienast et al. recorded the whole process of micrometastases formation from a single CTC in the mouse brain. 1 They identified four essential steps of successful micrometastases formation in the brain: initial arrest at blood vessel, early extravasation, perpetuation of a perivascular position and angiogenesis or vessel cooption. Here, in this study, we focus on understanding the detailed process and mechanism of CTC arrest in host blood vessels. CTC trafficking in blood circulation is an important route for primary tumor dissemination, 7 while the arrest and survival in the blood vessels is the most inefficient step in the metastatic cascade. Flowing through blood vessels, CTCs are interacting with not only humoral and cellular constituents of blood, but also with the endothelial cells of blood vessels. These interactions have a significant influence on the fate of metastatic tumor cells and the final outcome of metastasis. 8, 9 In fact, increasing data have shown that the circulation environment is actively hostile to CTCs. Wandering cancer cells can be pinched off, or even torn apart in circulation due to the hydrodynamic shear forces in circulation, which are often substantial in smaller vessels, especially at the bifurcation. 10, 11 Stable arrest in capillaries is important for the survival of wandering slenderized CTCs, which is also the prerequisite of extravasation and forming of distant metastases.
Several experiments suggested that CTCs could use specific cell surface receptors, such as integrins, to initially adhere to the luminal walls of arterioles and capillaries in certain tissues. 12 However, far more extensive evidence indicates that physical trapping within small vessels provides most wandering CTCs with the first foothold within a tissue, 1 but the detailed process of this occurrence is still unclear.
Recently, researchers detected the formation of plakoglobinmediated CTC clusters in the blood stream. These CTC clusters might help CTCs to survive and arrest at the vascular bifurcation in breast cancer metastasis. 13 However, extensive data show that CTCs are widely disseminating on an individual cellular basis and CTC clusters are rare in the circulation. 1, 13 Thus, revealing the mechanism of individual CTCs survival and arrest in hematogenous metastasis is necessary. Various animal models have been applied to examine the behaviors of CTCs in blood circulation, 1, 5, [14] [15] [16] each has its own advantages. However, none of them was able to reveal the whole picture of distal metastases formation from a circulating tumor cell, leaving the mechanism of individual CTCs arrest still controversial. Here, we established an experimental metastasis model using transparent zebrafish embryo (kdrl:eGFP; Casper mutant) to study the behavior of CTCs in blood circulation. Continuously confocal tracking astonishingly discovered a secondary morphological switch of the elongated intra-capillary CTCs back into a round shape. Genetic and pharmacological inhibition experiments indicated the necessity of the intra-capillary morphology switch (ICMS) for CTCs arrest. Further in vitro and in vivo intervention experiments identified a role of RhoA in the ICMS, which highlighted the use of specific RhoA inhibitors in targeting the arrest of CTCs in early tumor metastasis.
Material and Methods

Generating the kdrl:eGFP Casper mutant zebrafish line
Lines used in this study included kdrl: eGFP (zfin: s843Tg), kdrl: mCherry (zfin: zf527Tg), AB and Casper mutant (originally developed in Zon laboratory at Harvard Medical School). We established kdrl:eGFP Casper line by direct outcross and incross of kdrl: eGFP with Casper fish.
Zebrafish metastasis model
To establish the experimental zebrafish metastasis model, tumor cells (B16 or CT26, 50-100 cells per fish) were injected into the blood circulation of the 2dpf (days post fertilization) kdrl:eGFP Casper embryos through common cardinal vein (CCV). All the adult zebrafish used in this project were bred and maintained normally (temperature, 288C; pH 7.2-7.4; 14 hr on and 10 hr off light cycle). All tumor cellinjected zebrafish embryos were maintained at 338C. For the detailed microinjection method, see the Supporting Information.
Three-dimensional printing microstrains
Three-dimensional printing of micropore arrays via DLPbased bioprinter-DOPsL using photopolymerizable poly (ethylene glycol) diacrylate (PEGDA). The DMD chip used in this set-up is DLP-07 XGA from DLP Technology of Texas Instruments. The sliced images of the 3D model were loaded to the DMD chip that can continuously generate optical patterns and expose the photopolymerizable material in a layerby-layer manner. PEGDA solution (25 wt %) containing 1% lithium phenyl-2,4,6-trimethylbenzoylphosphinate was loaded to the sample stage of DOPsL and polymerized via patterned ultraviolet exposure to fabricate corresponding 3D structures. The fabricated 3D structure was incubated in PBS for 2 hr at 378C before use.
Imaging strategy
For live imaging of zebrafish, selected embryos were mounted in low melting point (LMP) agarose (1%, wt/vol) at the bottom of a 29 mm glass bottom dish and covered with fish water at 338C. Digital micrographs or real-time tracking images were taken either with a Zeiss Imager.Z1 fluorescence microscope (Carl Zeiss, Germany) or a Leica SP5 resonant scanning confocal (Leica, Germany). Super-resolution imaging of F-actin formation in living CTCs in zebrafish was obtained byZeiss LSM 880 Confocal Microscope with Airyscan (Carl Zeiss, Germany). For the entire mouse lung lobes and zebrafish body images, both fluorescent and bright-field images were taken by Zeiss SteREO Discovery.V20 stereomicroscope (Carl Zeiss, Germany). The tumor size, CTC diameter and actin filaments density analysis were based on fluorescent images and quantified by the corresponding imaging software.
RhoA activity evaluation
RhoA-GTP pull-down assay was performed using RhoA activation assay kit (Cell Biolabs) according to the manufacturer's instructions. Floating cultured tumor cells were collected 6 hr after they passed through the microstrains. Tumor cells were floating cultured in ultra-low attachment culture dishes for 6 hr, and those without passing through the microstrains were set as control.
The following procedures are included in the Supporting Information: cell culture and transfection, experimental and orthotopic mouse tumor model, immunofluorescence, microinjection, in situ perfusion and fixation, statistical analysis.
Results
Real-time imaging of single steps for distal metastases formation in kdrl:eGFP Casper zebrafish embryo
To investigate the single steps of distal metastases formation from individual CTCs, B16-RFP cells (50-100 cells/fish) were injected into the blood circulation of 2 dpf (days post fertilization) kdrl:eGFP Casper zebrafish embryo through common cardinal vein (CCV) (Fig. 1a) . 20 fish in total were selected and mounted in low melting point (LMP) agarose (1.5%, wt/ vol). Live imaging under a confocal (Leica SP5) was carried out immediately after zebrafish mounting (Fig. 1b) . CTC events of 541 in 20 fish were imaged, of which 43 (7.9%) were CTC clusters and 498 (92.1%) were individual CTCs (Supporting Information Figs. S1 and S2).
At 2 hpi (hours post injection), CTCs were widely distributed in the host circulation. Individual CTCs were commonly located in the brain and trunk capillaries, while CTC clusters (containing >2 cells) mainly resided at the caudal vein. As some individual CTCs kept wandering in the host circulation, cytoplasmic fragmentation was frequently observed (Supporting Information Fig. S2A ), which resulted in 30% cell loss in the first 2 hr (Fig. 1c) . At 2dpi (days post injection), we found that most survived CTCs (60% for B16 and 50% for CT26) were stably arrested in or extravasated from the host vasculature (Supporting Information Fig. S3 ), of which 39 (12.9%) were CTC clusters and 264 (87.1%) were individual CTCs (Fig. 1d ). At 6dpi, distal metastases were established and widely distributed in the zebrafish body (29 in brain, 14 in eyes, 23 in bladder, 69 in trunk and 39 in the tail, n 5 20) (Fig. 1e) . Interestingly, imaging tracking (zebrafish were imaged every 24 hr) indicated that most metastases (77.6%) were derived from individual CTCs, while the metastases from CTC clusters only occupied 22.4% of all metastases at 6dpi in kdrl:eGFP Casper zebrafish embryo. These results suggest that individual CTCs are the main source of distal metastases in the zebrafish metastasis model, although they cannot form metastases as efficiently as CTC clusters (86% survived into a metastases) (Fig. 1f ).
Stable arrest of individual CTCs is associating with intra-capillary morphology switch (ICMS)
To investigate the details of CTC arrest, we next imaged the individual CTCs (251 events in 12 fish) every 6 hr in the blood circulation. We found that individual CTCs were elongated when they entered the capillaries (Supporting Information Fig. S4 ). Interestingly, some CTCs could perform a secondary morphology-switch from a loaf to a sphere ( Fig.  2a) and were then stably trapped in capillaries (81%, Supporting Information movie1). By measuring the diameter of arrested CTCs, we found that the diameters of CTCs were significantly increased after the ICMS, which made the size of CTCs far larger than the internal diameter of capillaries (20 vs. 10 lm) (Fig. 2b) . Bitplane Imaris Surface analysis of the CTCs and blood vessels clearly showed the shape changes of single CTC during intravascular arrest and extravasation (Supporting Information Fig. S5 ). These results suggest that cell rounding might be related to the initial physical trapping (arrest) of individual CTCs. To further test our speculation, we then tracked a group of intravascular CTCs at different states (rounding or elongated) in the same zebrafish from 6 hr after cell seeding. Interestingly, we found that rounding CTCs were more likely to arrest and extravasate, compared to the elongated CTCs (Fig. 2d ).
As cell mitosis could result in cell swelling, 17 we labeled the nucleoli of B16-RFP cells with NLS peptides coupled GFP (nGFP) by lentivirus infection to test whether the rounding of CTCs was due to cell mitosis (Supporting Information Fig. S6A ). Previous study 18 and our test indicated that, during interphase, the nucleus contains one or more nucleoli. Once the cell entered mitosis, the nucleoli in the nucleus disappeared (Supporting Information Fig. S6B ). We then injected the B16-RFP-nGFP cells into the blood circulation of zebrafish as we described in Figure 1 . Interestingly, we found that the GFP1 nucleoli could be readily detected in most of the arrested rounding CTCs (Supporting Information Fig. S6C ), suggesting the rounding CTCs were actually in interphase.
To extend our results to mammals, we further investigated the arrest of CTCs in mouse experimental metastasis model. B16-GFP tumor cells were seeded into the mouse through the tail vein. Mouse lungs were harvested and sectioned at 2 hr and 5 days post cell injection. Multicolor immunostaining showed that tumor cells were mainly distributed as individual CTCs (Fig. 2g) . At 2 hpi, we found individual CTCs were either elongated or greatly deformed to fit the capillary channels (Fig. 2h, panel i) . At 5dpi, we found a portion of CTCs have already crossed the host vascular wall (Fig. 2h, panel ii) . Interestingly, for the arrested CTCs in the capillaries at 5dpi, the cells were generally in round shape (87%, 742 arrested CTCs in 5 mice were examined) (Fig. 2i) , which was similar to what we have observed in zebrafish metastasis model.
Intensive actin filaments assembly is associated with ICMS and arrest of CTCs
As cytoskeleton is critical for global architecture and shape of the cells, we next labeled the F-actin in living CTCs by pCMV LifeAct-GFP to investigate dynamics of F-actin filaments in the ICMS 19 ( Fig. 3a) . First, to prove the LifeAct is a qualified living tracer for the F-actin filaments, after transfected with LifeAct-GFP, tumor cells were either treated with lysophosphatidic acid (specifically activates Rho subfamily and induce the F-actin filaments formation) (LPA, 10 lM) 20 or Cytochalasin B (efficiently depolymerize the F-actin) (CB, 1 lM). Eight hours after drugs treatment, confocal imaging was applied and the results have confirmed that the LifeAct-GFP actually worked as expected (Fig. 3b) .
Then, we injected B16-LifeAct-GFP cells into the zebrafish circulation as previously described. A total of 19 CTCs were tracked by confocal (Zeiss Airyscan) for 12 hr till the rounding and arrest of the CTCs. Interestingly, intensive F-actin filaments formation was detected in rounding CTCs, while in those roaming CTCs, GFP signals were still diffusive (4-8 hr) (Fig. 3c) .
Next, to test the necessity of F-actin filaments formation in the ICMS and arrest of CTCs, we then used Cytochalasin B (CB, 1 lM for 4 hr) pretreatment to depolymerize the Factin of TCs before cell injection. 21 As expected, for the DMSO control groups, about 8-10 hr post-cell injection, most CTCs underwent ICMS and were arrested in the host capillaries, occasionally, extravasation was followed (Fig. 3d) . Interestingly, for the tumor cells that pretreated with CB, most of the cells failed to undergo ICMS. They were greatly elongated to various degrees depending on the shape of capillaries they entered (Fig. 3d) . CB-pretreated tumor cells generally kept roaming in the blood, suffering from hydrodynamic shear forces then torn apart (Fig. 3e) . Further in vitro and in vivo transplantation experiments showed that CB (1 lM for 4 hr) treatment has little or no effect on the growth of B16 cells or CT26 cells either in dish or in zebrafish perivitelline space (Supporting Information Fig. S7 ). Similar experiments were also performed in mouse experimental metastasis model by injecting CB or DMSO pretreated B16 cells through tail vein. Fluorescent imaging of the intact mouse lungs showed that CTCs efficiently entered into pulmonary capillaries in both groups (Fig. 3f, 20-min panel) . For the CB pretreated group, CTCs were generally in a loaf shape at 8 hpi (Fig. 3f, arrows) , while the CTCs in the control group were not. In addition, serial images and counting results (at 20 min, 8 hr, 24 hr and 10 days, n 5 3 mice for each time point) indicated a higher rate of CTC loss in the CB pretreated group, which is similar to our observation in zebrafish (Figs. 3e, 3g and 3h) . Thus, these experimental data suggested that F-actin assembly was essential for the ICMS and the intravascular arrest of CTCs.
Mechanical stress stimulates RhoA activation and F-actin filaments assembly in CTCs
We noticed that when the CTCs entering the host capillaries, they were greatly elongated ( Fig. 2a and Supporting Information Fig. S4 ). Such slenderized cells were suffering from extremely high mechanical stress from vascular luminal walls when passaging through these narrow straits. In fact, many researchers have reasoned that mechanical stress was an important parameter controlling the cell function and behaviors, which include but not limited to cell shape, cell invasion ability, differentiation and even immunogenicity. 22, 23 To test whether the mechanical stress from the capillaries was associating with F-actin assembly in CTCs, we designed a blood capillary-like micropore arrays (200 3 200 pores, pore diameter 5 8 lm, thickness 5 100 lm), which was printed using a DLP-based bioprinter-DOPsL with photopolymerizable poly(ethylene glycol) diacrylate (PEGDA). 24 B16 tumor cells were then pushed passing through the 3D printed strains at the same rate as they entered the zebrafish trunk capillaries (10 lm/min in our setting) (Figs. 4a and 4b) . The squeezed tumor cells were floating cultured in ultra-low attachment culture dish for 4 hr with or without the treatment of Rho kinase inhibitor (Y-27632, 2 lM). Then the floating cells were spun down using cytospin TM on microscope slides and stained using Rhodamine-phalloidin. To avoid the potential effect of cytospinning on the rounding of cells, cells were fixed immediately (<10 min) after the cytospinning. The staining results showed intensive F-actin filaments forming in the squeezed tumor cells, compared with the normally suspending tumor cells without passing through the strains (Fig.  4c) . In addition, no F-actin filaments was detected in the squeezed tumor cells treated with the Y-27632 (Fig. 4c) . We then evaluated the RhoA activity of tumor cells before and after passing through the strains by GTP bound RhoA pulldown assay. Western Blot analysis revealed that RhoA activity was significantly upregulated in those tumor cells that experienced strain squeeze, compared to the normal suspending tumor cells (Fig. 4d) .
Thus, the in vitro microdevice assay indicated that mechanical squeeze could increase the RhoA activity and also the assembly of F-actin fibers, which simulated the response of circulating CTCs in capillaries.
RhoA activation is necessary for the ICMS and arrest of CTCs in vivo
To further test the necessity of RhoA activation in the arrest of CTCs in vivo, we then modulate the RhoA activity in CTCs by overexpressing either the constitutively active RhoA-V14 or the dominant negative RhoA-N19 RhoA mutant in B16-RFP cells. 25 F-actin staining and wound healing experiments indicated that the Rho mutants actually worked as expected (Figs. 5a and 5b, Supporting Information  Fig. S8 ). RhoA pull-down assay also showed corresponding changes of RhoA activity at 48 hr post RhoA mutant transfection (Fig. 5c) . To evaluate the possible effect of Rho mutants on the growth of tumor cells, we made the growth curve of B16-RFP, B16-RFP-V14 and B16-RFP-N19 cells (Fig. 5d) . Indeed, we detected significant growth deficit of tumor cells transfected with RhoA-mutants in vitro, although it took 4-6 days to reach significant difference. Actually, we saw no detectable difference of growth rate for the initial 20-24 hr.
B16-RFP-RhoA-N19 cells and vehicle control tumor cells (50 cells per fish) were then injected into the zebrafish circulation. We then imaged and counted the CTCs at 6 hr, 22 hr and 5 days post the injection. Similar to our previous results, at 6hpi, no CTC extravasation was detected (Figs. 5e and 5f). However, comparing to the control group, we found much less B16-RFP-N19 were trapped in the brain capillaries and the detected B16-RFP-N19 cells were generally in elongated shape, which were different from the rounding CTCs in control group. This result suggested a role of RhoA signaling in the ICMS (rounding) of CTCs. At 22hpi, we imaged the brain of the same zebrafish again. We found that some of the arrested rounding B16-RFP cells at 6hpi have been extravasated at this time point. However, most of the B16-RFP-N19 cells that were imaged at 6hpi have disappeared or changed their locus. And, the detected B16-RFP-N19 cells were still in elongated shape (Figs. 5g and 5h ). This result indicated that the elongated B16-RFP-N19 CTCs were unstable in the capillaries and suggested the necessity of RhoA signaling in the intravascular arrest of CTCs. At 5dpi, as expected, much less metastases were detected in the RhoA-N19 group, compared to the control group. Interestingly, we also noticed that the size of the RhoA-N19 metastases was much smaller (Figs. 5i and 5j ). This could be due to the relatively slower growth rate of B16-RhoA-N19 cells that have been evaluated in vitro (Fig. 5d) .
Thus, these results together suggested a role of RhoA signaling at the initial step of metastasis cascade, especially for the intravascular arrest of CTCs.
Transient Fasudil treatment efficiently eliminates pulmonary metastasis in mouse melanoma and breast cancer model
Our experimental results indicated the necessity of RhoA activation in the ICMS and arrest of CTCs, which gives a rationale to test the effect of a clinical approved RhoA kinase inhibitor, Fasudil, in inhibiting the distant metastases during hematogenous metastasis. 26, 27 We first tested a transient Fasudil treatment in the experimental mouse metastasis model by directly injecting B16-RFP cells through the tail vein. The pharmacokinetic variables of Fasudil (short serum half-life, rapid conversion to metabolite) dictated the test of a variety of dosing regimens. In one group, Fasudil was given i.v twice daily at 60 mg/kg/ d. For the other two groups, Fasudil was given p.o. either twice daily at 200 mg/kg/d or continuously in the drink at 228 mg/kg/d. Because the RhoA activation was hypothesized to function early in the metastasis cascade, Fasudil treatment was given for the first 3 days after cell seeding (the arrest time window, Fig. 6a ). Mice were sacrificed on day15 (n 5 8 for each group). As shown in Figure 6 , the number of pulmonary nodules was significantly reduced in Fasudiltreated mice compared with the control group (Figs. 6b and  6c) .
We next investigate the effect of Fasudil on an orthotopic model, in which breast cancer 4T1 cells were implanted into the mammary fat pad. Fasudil treatment started on day 10 when the primary tumors in the mammary fat pad were palpable. From the day on, Fasudil was given p.o. continuously in the drink for 228 mg/kg/d till the sacrifice on Day 36 (Fig. 6d) . As shown in Figure 6 , the number of pulmonary nodules in the Fasudil-treated mouse was dramatically reduced compared with the vehicle group (Figs. 6e-6g) . However, we noticed that, in either experimental melanoma metastasis model or the breast cancer orthotopic model, the size of big pulmonary nodules (Dia >3 mm) in Fasudil groups and control group were similar, suggesting that Fasudil treatment could specifically inhibited the incidence of tumor metastasis, but had no or little effect on the growth of established ones.
Discussion
In this study, we have established a new animal model to monitor the single-step of hematogenous metastasis. This model allows the tracking of individual metastatic tumor cells in the blood circulation over hours to days till the formation of the distant metastases. This has been a major challenge for tumor metastasis research in the past decades. Our general knowledge regarding metastasis is mainly based on the onetime histological experiments, which cannot track the future or the past of a phenomenon observed. And for the behavior description of metastatic tumor cells in circulation, researchers need to arbitrarily predict based on some static images or staining. Live tracking of tumor metastasis has been extensively explored in the past few years, 1, 5, 14, 15, 28 but they either lack the resolution to study single CTC or has tracking number limitation to do drug screen.
Our model offers several advantages: first, recipients can be directly fixed under a fluorescent microscope or confocal in culture systems due to their small size and transparency; second, without the body size restriction, we can assess the metastatic distribution throughout the recipients' body at all stages; secondly, using the multipoint location function of a confocal we can track dozens of animals at one time. This allows us to differentiate between dormant, dying and proliferating cells and even follow single cells that the undergo circulating, arrest, extravasation and forming distal metastases over days to weeks. In this way, we were able to detect previously hidden mechanisms of hematogenous metastasis and even do downstream drug screen.
Using a kdrl:eGFP Casper zebrafish model, we found similar results to previous reports that the initial arrest of blood- Interestingly, single circulating cell tracking indicates that the CTCs' intra-capillary shape switch from a loaf to a sphere represents a mechanism for the physical block (arrest) of individual CTCs in host capillaries. This process of shape transformation is not related to vascular wall adhesion, but results from the intensive F-actin filaments formation in the circulating cell cytoplasm. Further in vitro and in vivo experiments discovered that activation of RhoA-ROCK pathway by mechanical stress from the blood capillaries was responsible for the increment of F-actin filaments formation and the latter ICMS of CTCs. This pathway might be a useful target to individual CTCs in metastasis.
Fasudil [1-(5-isoquinolinesulfonyl)-homopiperazine] is a well-described orally available Rho kinase inhibitor, 26 which has been approved in Japan and China for the treatment of cerebral vasospasm following surgery for associated cerebral ischemic symptoms. 29 Following p.o. administration, Fasudil is converted into the active metabolite 1-(hydroxy-5-isoquinoline sulfonyl-homopipera-zine) (Fasudil-OH). In patients, Fasudil is well tolerated without any severe adverse reactions. 30 Previous studies indicated that Fasudil or Fasudil-OH could effectively inhibit tumor metastasis and significantly prolong the survival rate of tested animals, including mice and rats. 31 Similar to our results, in the previous studies, Fasudil treatment has no effect either on the proliferation of in vitro culturing tumor cells or in vivo growth rate of primary tumor cells which inculdeMDA-MB-231, HT1080 breast cancer cells, MM1 neuroblastoma cells and Walker 256 cells. 31 Thus, it is highly possible that Fasudil exerts its antitumor activity by affecting tumor metastasis rather than by directly affecting cellular proliferation. However, establishment of distal metastasis depends on successful progression through multiple steps, from shedding of tumor cells by the primary tumor into the bloodstream (or lymphatic) through CTCs arrest, extravasation and eventual growth at distant foci. [32] [33] [34] Specifically, at which step, the RhoA/ROCK inhibitor-Fasudil affect the metastasis is still unclear.
Here, our in vitro and zebrafish experimental data have shown that interruption of the RhoA/ROCK pathway could efficiently inhibit the F-actin filaments formation and ICMS of individual tumor cells, which gives a rationale to test the effect of Fasudil in affecting the initial arrest of CTCs during hematogenous metastasis. Different to previous studies, Fasudil was only given to the time window, when the CTC arrest was happening (Fasudil treatment for the first 3 days in melanoma experimental metastasis model and from 10dpi in the spontaneous breast cancer metastasis model). Our results in both mouse models indicate Fasudil can efficiently inhibit the incidence of tumor metastasis in the mouse lung, which provided an experimental basis to expand the use of Fasudil to treat patients with tumor metastasis.
The findings of our study can help explain some of the clinical aspects and experimental phenomena of tumor metastasis. Recently, researchers found macrophages that swallowed metastatic tumor cells' protrusion could build a pre-metastatic niche for CTCs. 35 In our study, we observed in real-time the production of "tumor protrusion" and found that they were actually cytoplasmic fragmentation of CTCs by blood shear-force as they traveled in the narrow and complex host capillaries. Our results also explained, at least partly, that the higher survival propensity of CTC clusters compared to individual ones, which was recently reported in breast cancer metastasis. 13 Due to the hydrodynamic shear forces in the circulation, which are often substantial in smaller vessels, especially at the bifurcation, we observed that individual CTCs circulating in capillaries could easily be pinched off, or even torn apart. The size of CTC clusters was big enough to be efficiently blocked at relatively bigger vessels and experienced less hydrodynamic shear force, especially for those cells that were hiding inside the clusters.
Our model has some limitations, however. Zebrafish are generally cultured at 338C in our experimental setting, which is not a perfect temperature for mammal tumor cell growth. Because of the size restriction, we could only track a single tumor cell till it forms relative small metastases (Dia < 500 lm). Tumor cells used in our experiment were limited to mouse-originated cell lines, the study of their interaction with the homogenous blood cells and blood platelet are impossible. Also, we did not investigate the possible roles of concurrently metastasizing parenchyma cells and the impact of the preexistence of primary macro tumor. 36 Previous studies showed that RhoA activation could efficiently induce the actin filament assembly; while inhibition of RhoA activity can inhibit the formation of actin filament and induce the shifting of G-actin to F-actin. 22 Thus, sometimes, in addition with the RhoA-GTP pull-down assay, we use the actin filament assembly as the biochemical reader for the RhoA activity. However, there are other GTPase that can still efficiently affect the F-actin assembly, such as cdc42 and RAC. Thus, we cannot rule out the potential activity of these proteins in the arrest of CTCs in our model. However, a live animal model to observe metastasis as a whole process, especially in real time, has provided new insights into tumor metastasis formation and an opportunity to experimentally address unanswered questions of metastasis research. CTC arrest is the essential and inefficient step of metastatic cascade, representing a potential target to treat the early hematogenous metastasis, understanding the mechanism of CTC arrest provides a possibility to better tailor anti-metastasis therapies in the future.
